September 17, 2019

Generium Launches First Biosimilar of Dornase Alfa; Becomes Sixth Approved Product Using Selexis SUREtechnology Platform

Read More
September 05, 2019

ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform

Read More
June 20, 2019

Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing

Read More

Media Downloads